GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
O

Orchid Pharma ORCHPHARMA.NS · INR

Health Care · NSE · 🇮🇳 India

Compare

884.00

+1.84%

Close of 9 Nov 2026, in INR

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in INR, from our data supplier.

FY2026

Revenue

₹8.11bn

FY2017FY2026

Net income

₹205.5m

FY2017FY2026

Free cash flow

−₹2.74bn

FY2017FY2026

Shareholders' equity

₹12.88bn

FY2017FY2026

Income statement

Fiscal years

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Revenue₹8.11bn₹9.22bn₹8.19bn₹6.66bn₹5.60bn₹4.50bn₹4.84bn₹6.00bn₹6.83bn₹7.97bn
Research and development₹134.2m₹83.7m₹70.9m₹63.6m₹66.3m₹48.1m₹119.3m₹139.6m₹177.3m₹376.0m
Operating income₹56.8m₹1.10bn₹940.6m₹618.9m−₹248.9m−₹439.1m−₹701.0m−₹736.6m−₹895.0m−₹1.09bn
Net income₹205.5m₹996.6m₹921.7m₹463.2m−₹19.5m−₹1.17bn−₹1.31bn₹694.1m−₹3.53bn−₹4.95bn
Diluted earnings per share4.0519.6718.199.73-0.48-28.58-32.127.80-39.66-55.71

Balance sheet

At each fiscal year end

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Total assets₹19.11bn₹16.88bn₹15.54bn₹12.25bn₹11.11bn₹12.37bn₹14.60bn₹30.77bn₹31.25bn₹32.56bn
Cash and short-term investments₹840.7m₹1.83bn₹45.2m₹275.2m₹48.3m₹315.1m₹899.0m₹3.26bn₹3.06bn₹2.57bn
Total liabilities₹6.23bn₹4.21bn₹3.84bn₹5.37bn₹4.63bn₹5.84bn₹6.94bn₹37.81bn₹39.17bn₹37.22bn
Debt₹3.63bn₹1.75bn₹1.35bn₹3.31bn₹2.68bn₹4.53bn₹5.66bn₹32.30bn₹32.02bn₹31.06bn
Shareholders' equity₹12.88bn₹12.67bn₹11.69bn₹6.89bn₹6.47bn₹6.53bn₹7.66bn−₹7.04bn−₹7.92bn−₹4.67bn
Shares outstanding51m51m51m48m41m41m41m89m89m89m

Cash flow

Fiscal years

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Cash from operations₹1.10bn₹192.2m₹1.26bn₹183.4m₹924.7m₹235.9m₹808.0m₹120.2m₹91.8m₹4.01bn
Capital spending−₹3.84bn−₹1.50bn−₹648.1m−₹849.1m−₹144.0m−₹6.0m−₹42.4m−₹66.3m−₹62.1m−₹86.8m
Free cash flow−₹2.74bn−₹1.31bn₹611.8m−₹665.8m₹780.7m₹229.8m₹765.6m₹54.0m₹29.7m₹3.92bn

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
Revenue₹3.04bn₹2.38bn₹2.07bn₹1.94bn₹1.73bn₹2.37bn₹2.17bn₹2.23bn
Operating income₹30.5m₹180.0m₹309.6m−₹103.8m₹55.2m₹191.1m₹618.9m₹217.1m
Net income₹32.2m₹237.8m−₹126.1m−₹57.2m₹149.1m₹222.9m₹207.8m₹272.4m
Diluted earnings per share0.644.69-2.49-1.132.944.404.105.38
Cash from operations———₹115.0m————
Capital spending———−₹1.59bn————
Free cash flow———−₹1.47bn————
Total assets—₹19.11bn—₹17.22bn—₹16.88bn—₹16.35bn
Cash and short-term investments₹832.1m₹840.7m₹1.49bn₹1.50bn₹1.80bn₹1.83bn₹2.44bn₹2.48bn
Debt—₹3.58bn—₹2.82bn—₹1.75bn—₹1.65bn
Shareholders' equity₹12.88bn₹12.88bn₹12.74bn₹12.74bn₹12.67bn₹12.67bn₹12.24bn₹12.24bn

Financial ratios

Data as of 21 Sept 2026

FY2026FY2025FY2024FY2023FY2022FY2021
Operating margin0.7%11.9%11.5%9.3%-4.4%-9.8%
Net margin2.5%10.8%11.3%7.0%-0.3%-25.9%
Return on equity1.6%7.9%7.9%6.7%-0.3%-17.8%
Return on assets1.1%5.9%5.9%3.8%-0.2%-9.4%
Free cash flow yield9.0%3.1%3.5%2.0%2.4%0.5%
Revenue growth-12.0%12.6%23.0%19.0%24.3%-7.0%
Earnings growth-79.4%8.1%99.0%-2473.8%-98.3%-11.1%
Current ratio2.45x2.83x3.04x1.35x1.65x3.87x
Debt to equity0.28x0.14x0.12x0.48x0.41x0.69x
Equity ratio67.4%75.1%75.3%56.2%58.3%52.8%
Interest coverage0.43x7.57x5.62x1.88x-0.74x-0.84x
R&D as a share of sales1.7%0.9%0.9%1.0%1.2%1.1%
Buybacks as a share of market value-0.1%0.0%-6.4%-16.8%-0.0%0.1%

Growth per year

Compound annual rate

3 years5 years10 years
Revenue6.8%12.5%-0.6%
Operating income-54.9%——
Net income-23.7%——

Average margins

Over each period

1 year3 years5 years10 years
Operating margin6.7%8.4%4.8%-6.0%
Net margin6.9%8.0%3.3%-13.7%

Valuation history

At each fiscal year end

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Price to earnings219.238.699.373.3-761.0-13.8-3.80.7-0.1-0.3
Price to sales5.54.211.25.12.63.61.00.10.10.2

Dividends and splits

Per share, in the currency the company pays

Paid for 0 years. Last went ex-dividend on 13 Sept 2012.

FY2013FY2012FY2011FY2010FY2009FY2008FY2007FY2006
Paid in the year653.88653.882,179.599217.96653.88653.88653.88581.226
  • 100-to-0.4588 reverse split · 25 Jul 2019
  • 3-for-2 split · 15 Sept 2005

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.